AnalystsMichael OkunewitchMichael Okunewitch's Stock Forecasts
AnalystsMichael Okunewitch
Analyst Ranking
Bottom 15%
#4212 out of 4928 analysts
Average Return
-1.14%
Win Rate
23%6 out of 26
Risk vs Reward
Poor
Good
Michael Okunewitch's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Citius Oncology IncCTOR | +455.32% | $0.94 | $5.22 | 2024-11-27 - 2025-07-02 | Strong Buy |
Lexaria Bioscience CorpLEXX | +215.61% | $0.87 | $2.73 | 2023-07-21 - 2024-07-19 | Strong Buy |
Anebulo Pharmaceuticals IncANEB | +79.21% | $1.01 | $1.81 | 2025-05-15 - 2025-07-02 | Strong Buy |
Lineage Cell Therapeutics IncLCTX | +75.86% | $0.58 | $1.02 | 2025-01-10 - 2025-07-02 | Strong Buy |
Chemomab Therapeutics LtdCMMB | +52.33% | $0.81 | $1.24 | 2024-05-13 - 2025-05-12 | Strong Buy |
Michael Okunewitch Analyst Color
Get additional color on Michael Okunewitch's coverage of popular stocks
Michael Okunewitch's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Hcw Biologics IncHCWB | 2 | Strong Buy | $35.00 | +739.33% | Maintains | a month ago |
Anebulo Pharmaceuticals IncANEB | 2 | Strong Buy | $3.00 | +65.75% | Maintains | 2 months ago |
Radiopharm Theranostics LtdRADX | 1 | Strong Buy | $12.00 | +195.57% | Initiates Coverage On | 2 months ago |
Chemomab Therapeutics LtdCMMB | 2 | Strong Buy | $7.00 | +508.70% | Maintains | 4 months ago |
Mainz Biomed NvMYNZ | 1 | Strong Buy | $14.00 | +879.02% | Initiates Coverage On | 5 months ago |
Lineage Cell Therapeutics IncLCTX | 1 | Strong Buy | $3.00 | +194.12% | Maintains | 6 months ago |
Citius Oncology IncCTOR | 1 | Strong Buy | $3.00 | -42.53% | Initiates Coverage On | 7 months ago |
Ocugen IncOCGN | 1 | Strong Buy | $4.00 | +331.97% | Initiates Coverage On | 9 months ago |
Fibrobiologics IncFBLG | 1 | Strong Buy | $12.00 | +1,867.21% | Initiates Coverage On | 9 months ago |
Longeveron IncLGVN | 2 | Strong Buy | $6.00 | +361.54% | Maintains | 10 months ago |
Lexaria Bioscience CorpLEXX | 2 | Strong Buy | $12.00 | N/A | Maintains | a year ago |
Dmk Pharmaceuticals CorpDMKPQ | 1 | Strong Buy | $1.50 | N/A | Initiates Coverage On | 2 years ago |
Acrivon Therapeutics IncACRV | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 2 years ago |
Kiora Pharmaceuticals IncKPRX | 3 | Strong Buy | $18.00 | N/A | Maintains | 2 years ago |
Alzamend Neuro IncALZN | 1 | Strong Buy | $2,025.00 | N/A | Initiates Coverage On | 2 years ago |
Mediwound LtdMDWD | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 3 years ago |
Biorestorative Therapies IncBRTX | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 3 years ago |
Atlantic International CorpATLN | 1 | Strong Buy | $120.00 | N/A | Initiates Coverage On | 3 years ago |
Atai Life Sciences NvATAI | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 4 years ago |
Citius Pharmaceuticals IncCTXR | 1 | Strong Buy | $100.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.